Literature DB >> 24059440

Pheochromocytoma presenting with rhabdomyolysis and acute renal failure: a case report.

Huseyin Celik1, Ozlem Celik, Sibel Guldiken, Volkan Inal, Fulya Oz Puyan, Armagan Tugrul.   

Abstract

Rhabdomyolysis ranges from an asymptomatic illness with elevated creatine kinase levels to a life-threatening condition associated with extreme elevations in creatine kinase, electrolyte imbalances, acute renal failure, and disseminated intravascular coagulation. The most common causes are crush injury, overexertion, alcohol abuse, certain medicines, and toxic substances. A number of electrolyte abnormalities and endocrinopathies, including hypothyroidism, thyrotoxicosis, diabetic ketoacidosis, nonketotic hyperosmolar state, and hyperaldosteronism, cause rhabdomyolysis. Rhabdomyolysis and acute renal failure are unusual manifestations of pheochromocytoma. There are a few case reports with pheochromocytoma presenting rhabdomyolysis and acute renal failure. Herein, we report a case with pheochromocytoma crisis presenting with rhabdomyolysis and acute renal failure.

Entities:  

Mesh:

Year:  2013        PMID: 24059440     DOI: 10.3109/0886022X.2013.832856

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  3 in total

1.  Clinical characteristics and outcomes of pheochromocytoma crisis: a literature review of 200 cases.

Authors:  Y Ando; Y Ono; A Sano; N Fujita; S Ono; Y Tanaka
Journal:  J Endocrinol Invest       Date:  2022-07-20       Impact factor: 5.467

2.  Continuous renal replacement therapy for haemodynamic collapse and rhabdomyolysis induced by pheochromocytoma crisis.

Authors:  Xi Zhou; Chuhuan Zhao; Xiafei Feng; Anweshan Samanta; Yi Nuo Lin; Jun Chen; Xiaochun Dai; Xia Hong; Qiangli Xie; Weijian Huang
Journal:  ESC Heart Fail       Date:  2016-08-15

3.  REMISSION OF LONGSTANDING INSULIN-TREATED DIABETES MELLITUS FOLLOWING SURGICAL RESECTION OF PHEOCHROMOCYTOMA.

Authors:  Owain M Leng; Asgar C Madathil
Journal:  AACE Clin Case Rep       Date:  2019-01-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.